Company Filing History:
Years Active: 2011-2012
Title: Leanda Jane Kindon: Innovator in Pharmaceutical Chemistry
Introduction
Leanda Jane Kindon is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating inflammatory diseases. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
One of her latest patents is focused on an anti-inflammatory macrolide. The compound, known as 3'-N-demethyl-4″-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A, is designed for the treatment of neutrophil-dominated inflammatory diseases. This patent includes compositions comprising the compound, its use in treatment, and methods for its preparation.
Another significant patent involves pyrazolo[3,4-b]pyridine compounds, which serve as phosphodiesterase type IV (PDE4) inhibitors. The invention provides a compound with the formula N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo [3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl)(methyl)amino]octanoyl}amino)benzamide. This compound is intended for the treatment and prophylaxis of inflammatory and allergic diseases, including chronic obstructive pulmonary disease (COPD), asthma, and rhinitis.
Career Highlights
Leanda has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. Her experience in these organizations has allowed her to contribute to innovative research and development projects.
Collaborations
Throughout her career, Leanda has collaborated with notable professionals in her field, including Caroline Jane Day and Julien Bruno Douillet. These collaborations have further enhanced her research and development efforts.
Conclusion
Leanda Jane Kindon is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of inflammatory diseases. Her patents reflect her commitment to innovation and her contributions to the scientific community.